ArticleJTCVS open2021

Commentary: Adjuvant chemotherapy after trimodal therapy for esophageal carcinoma: A bitter pill to swallow.

Valerie X Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.